Breast Cancer Clinical Trial
Official title:
Shared Decision Making on Care Pathways and CAMs: A Pilot Study
Shared Decision Making on Care Pathways and alternative and complementary medicine (CAMs) : A Pilot Study. Study whose aim is to evaluate the feasibility of a study proposing a therapeutic education consultation leaning on the usual care pathway by estimating the recruitment capacity over 4 months as well as the acceptance rate of the study among patients diagnosed with breast cancer.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | August 2024 |
Est. primary completion date | January 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients recently diagnosed with breast cancer at Grenoble Alpes University Hospital - In situ or invasive breast cancer, locally advanced but without metastasis, demonstrated on histology - ECOG ( Eastern Cooperative Oncology Group) performance status 0, 1 or 2 - Cancer treated with chemotherapy, radiotherapy and/or surgery - Having signed an informed consent after information, being of age and able to express consent, affiliated to a social security system Exclusion Criteria: - Pregnant, breastfeeding or parturient women - women who do not speak French; - patients participating in another research protocol - Metastatic breast cancer, diagnosed psychiatric pathologies that make it impossible to perform the procedure, history of cancer except for cervical cancer in situ or basal cell cancer - Subjects in a period of exclusion from another study, - Subject under administrative or judicial supervision - Subject unable to be contacted in case of emergency |
Country | Name | City | State |
---|---|---|---|
France | Chu Grenoble | Grenoble | |
France | Pole Sante Saint Martin D'Heres | Saint-Martin-d'Hères |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Grenoble | Laboratoire TIMC-IMAG, University Grenoble Alps |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Feasibility of a study proposing a therapeutic education consultation linked to the usual course of care | The investigators wish know the recruitment capacity in this study. To do this, the investigators will estimate the number of people included over 8 months (time of recruitment in the study). | 8 month | |
Secondary | Evaluate literacy in the care pathway. | "Health Literacy Questionnaire" (HLQ) at 6 month post intervention. Questionnaire contains 2 parts : P1 with 23 questions, and P2 with 21 questions.
Coding: P1Q1 to P1Q23 Strongly Disagree = 1 Disagree = 2 Agree = 3 Strongly Agree = 4 P2Q1 to P2Q21 Cannot do or always difficult, = 1 Usually difficult = 2 Sometimes difficult = 3 Usually easy = 4 Always easy = 5 The HLQ consists of 9 scales representing 9 dimensions of health literacy. Each HLQ scale has 4-6 items. The HLQ does not provide one overall summative score. The scoring of the HLQ is 9 scale scores, calculated by averaging the item scores within each scale with equal weighting. The 9 scale scores will reflect a person's strengths and needs in the different dimensions of health literacy. For Scales 1 to 5, the score range is between 1 and 4 For Scales 6 to 9, the score range is between 1 and 5 |
inclusion, 6 month | |
Secondary | Satisfaction with improvement in orientation to the care pathway | To assess the HQL (Health Literacy Questionnaire) Minimal Clinically Interesting Difference at 6 months after the intervention.
The investigators wish to assess the Minimal Clinically Interesting Difference at 6 months after the intervention by comparing the response about the satisfaction with improvement in orientation to the care pathway (0: No improvement, 1 : Slight improvement, 2 : Good improvement, 3 : Excellent improvement) " to the HLQ dimensions of interest. |
6 month | |
Secondary | Success in orienting to the care pathway | The investigators wish to assess PALS by comparing the response to the question "Do you feel able to learn about services and supports to ensure that all your health needs are met? ( YES/NO)" to the HLQ dimensions of interest.
PALS will be binary, either patients feel able to orient themselves in the care pathway or they do not feel able to do so |
inclusion, 6 month | |
Secondary | Assess satisfaction with the current care pathway | Bilateral 6-item Likert scale at 6 months after surgery (-3: very dissatisfied to +3 very satisfied ) | 6 month | |
Secondary | Collect the patient experience | Semi-directive interview conducted at 6 months after the intervention. This interview will be carried out only for some patients of the study until data saturation. | 6 month | |
Secondary | To assess patient adherence, patient believes in the mechanics of TACs operation. | CHBQ questionnaire completed at inclusion (pre-intervention) and at 6 months (post-intervention by the patient.
This questionnaire is composed of 10 propositions. The total score varies between 10 (total disagreement with all the proposals) and 70 (total agreement with all the proposals). The authors suggest that above the median score of 40, the respondent has a positive attitude towards TACs and conversely a negative attitude towards TACs for a score below 40. |
inclusion, 6 month | |
Secondary | To assess co-variance between oncologist and patient beliefs in TACs operating mechanisms | CHBQ questionnaire completed by the oncologist at the beginning of the study (before the start of the inclusion).
This questionnaire is composed of 10 propositions. The total score varies between 10 (total disagreement with all the proposals) and 70 (total agreement with all the proposals). The authors suggest that above the median score of 40, the respondent has a positive attitude towards TACs and conversely a negative attitude towards TACs for a score below 40. |
Inclusion | |
Secondary | To assess the use of TACs | If individuals have used TACs, then they are offered a simplified and adapted version of the CAMP-Q (Complementary and Alternative Medicine Practitioner Use Questionnaire) completed at inclusion and 6 months after the intervention by the patient.
This questionnaire includes 49 questions and the objective will be to evaluate if the patient has used one or more alternative medicines (1) or no alternative medicine (0). It don't have a rating |
inclusion, 6 month | |
Secondary | To assess satisfaction with TACs | Bilateral 6-item Likert scale (-3: very dissatisfied to +3 very satisfied) at baseline and 6 months after the procedure ONLY if at least one complementary alternative technique was checked in answer n°1 of the CAMP Q questionnaire.
This is to have a before and after evaluation. |
inclusion, 6 month | |
Secondary | To assess satisfaction with oncology care. | Two-sided 6-item Likert scale (-3: very dissatisfied to +3 very satisfied ) at 6 months post intervention. These goals are only evaluated for patients in the AFTER group | 6 month | |
Secondary | Assess patient satisfaction with the procedure. | Two-way 6-item Likert scale (-3: very dissatisfied to +3 very satisfied ) evaluated after the intervention and at 6 months. This objective is only evaluated for patients in the AFTER group | After intervention, 6 month | |
Secondary | Assess patient recommendation of the intervention | Two-way Likert scale with 4 items (-2 not at all agree to +2 completely agree ) evaluated after the intervention and at 6 months. This objective is only evaluated for patients in the AFTER group | After intervention, 6 month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |